RNWL
INTERNATIONAL REGISTRATION RENEWED
31/10/2024
Voltar para busca
Dado oficial do USPTO
ACACIA PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
31/10/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
06/01/2015
Data de registro
21/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/06/2016
Última transação
05/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
PINO, BRIAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "ACACIA PHARMA" and the stylized design of an irregular oval shape with a block positioned above it that has a pointed end at the left edge and a flat end at the right edge. The design and word "ACACIA" are in black and the word "PHARMA" is in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Titulares e representantes
Titulares
Acacia Pharma Limited
Representantes
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Sanitary preparations for medical purposes; pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV); pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV); pharmaceutical preparations for the management of xerostomia (dry mouth); pharmaceutical preparations for the management of cancer cachexia; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations for the management of cancer side effects; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations associated with surgery
Classe 42
Scientific and technological services and research and design relating theretoscientific researchanalysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluationdevelopment and testing services; pharmaceutical researchinspection and testing; medical and pharmaceutical research services; scientific research for medical purposes in the area of cancerous disease; pharmaceutical researchinspectiontestingdevelopment and evaluation of pharmaceutical and veterinary preparationssanitary preparations for medical purposesdietetic food and substances adapted for medical or veterinary usepharmaceutical preparations for the management of post-operative nausea and vomiting (PONV)pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV)pharmaceutical preparations for the management of xerostomia (dry mouth)pharmaceutical preparations for the management of cancer cachexiapharmaceutical preparations for the management of cancer treatment side effectspharmaceutical preparations for the management of side effects of surgerypharmaceutical preparations for the management of cancer side effectspharmaceutical preparations for the treatment of cancerpharmaceutical preparations associated with surgery; informationadvisory and consultancy services relating to the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
11/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/08/2023
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
04/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/08/2022
ES71
TEAS SECTION 71 RECEIVED
06/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/01/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/01/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/11/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/10/2016
FIMP
FINAL DISPOSITION PROCESSED
20/10/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
21/06/2016
PUBO
PUBLISHED FOR OPPOSITION
05/04/2016
NPUB
NOTICE OF PUBLICATION
16/03/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/03/2016
ALIE
ASSIGNED TO LIE
23/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2016
ALIE
ASSIGNED TO LIE
10/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2016
RFNT
REFUSAL PROCESSED BY IB
24/10/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2015
RFRR
REFUSAL PROCESSED BY MPU
08/10/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2015
CNRT
NON-FINAL ACTION WRITTEN
07/10/2015
MAFR
APPLICATION FILING RECEIPT MAILED
06/10/2015
DOCK
ASSIGNED TO EXAMINER
02/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/10/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACACIA PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.